Scalpel or SABR for treatment of early-stage lung cancer: Clinical considerations for the multidisciplinary team

Cancers

Volumn 3, Issue 3, 2011, Pages 3432-3448

  Shirvani, Shervin M ^a   Chang, Joe Y ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Early stage non small cell lung cancer; Stereotactic ablative body radiotherapy; Stereotactic body radiation therapy

Indexed keywords

ADVERSE OUTCOME; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE EFFECTIVENESS; EARLY CANCER; HEALTH CARE QUALITY; HUMAN; IMMOBILIZATION; INTERMETHOD COMPARISON; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; METASTASIS; OVERALL SURVIVAL; PATIENT POSITIONING; PATIENT SELECTION; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION HAZARD; REVIEW; SCALPEL; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; TUMOR VOLUME;

EID: 80053219245     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3033432     Document Type: Review

References (75)

1. Loo, B.W.; Chang, J.Y.; Dawson, L.A.; Kavanagh, B.D.; Koong, A.C.; Senan, S.; Timmerman, R.D. Stereotactic ablative radiotherapy: What's in a name? Pract. Radiat. Oncol. 2011, 1, 38-39.
2. Dosoretz, D.E.; Galmarini, D.; Rubenstein, J.H.; Katin, M.J.; Blitzer, P.H.; Salenius, S.A.; Dosani, R.A.; Rashid, M.; Mestas, G.; Hannan, S.E. et al. Local control in medically inoperable lung cancer: An analysis of its importance in outcome and factors determining the probability of tumor eradication. Int. J. Radiat. Oncol. Biol. Phys. 1993, 27, 507-516.
3. Kaskowitz, L.; Graham, M.V.; Emami, B.; Halverson, K.J.; Rush, C. Radiation therapy alone for stage I non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 1993, 27, 517-523.
4. Timmerman, R.; Paulus, R.; Galvin, J.; Michalski, J.; Straube, W.; Bradley, J.; Fakiris, A.; Bezjak, A.; Videtic, G.; Johnstone, D. et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303, 1070-1076.
5. Onishi, H.; Shirato, H.; Nagata, Y.; Hiraoka, M.; Fujino, M.; Gomi, K.; Niibe, Y.; Karasawa, K.; Hayakawa, K.; Takai, Y. et al. Hypofractionated stereotactic radiotherapy (Hypofxsrt) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study. J. Thorac. Oncol. 2007, 2, S94-S100.
6. Fakiris, A.J.; McGarry, R.C.; Yiannoutsos, C.T.; Papiez, L.; Williams, M.; Henderson, M.A.; Timmerman, R. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study. Int. J. Radiat. Oncol. Biol. Phys. 2009, 75, 677-682.
7. Baumann, P.; Nyman, J.; Lax, I.; Friesland, S.; Hoyer, M.; Rehn Ericsson, S.; Johansson, K.A.; Ekberg, L.; Morhed, E.; Paludan, M. et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the nordic countries. Acta Oncol. 2006, 45, 787-795.
8. Nagata, Y.; Negoro, Y.; Aoki, T.; Mizowaki, T.; Takayama, K.; Kokubo, M.; Araki, N.; Mitsumori, M.; Sasai, K.; Shibamoto, Y. et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int. J. Radiat. Oncol. Biol. Phys. 2002, 52, 1041-1046.
9. Nagata, Y.; Takayama, K.; Matsuo, Y.; Norihisa, Y.; Mizowaki, T.; Sakamoto, T.; Sakamoto, M.; Mitsumori, M.; Shibuya, K.; Araki, N. et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int. J. Radiat. Oncol. Biol. Phys. 2005, 63, 1427-1431.
10. Hara, R.; Itami, J.; Kondo, T.; Aruga, T.; Uno, T.; Sasano, N.; Ohnishi, K.; Kiyozuka, M.; Fuse, M.; Ito, M. et al. Clinical outcomes of single-fraction stereotactic radiation therapy of lung tumors. Cancer 2006, 106, 1347-1352.
11. Grills, I.S.; Mangona, V.S.; Welsh, R.; Chmielewski, G.; McInerney, E.; Martin, S.; Wloch, J.; Ye, H.; Kestin, L.L. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J. Clin. Oncol. 2011, 28, 928-935.
12. Ricardi, U.; Filippi, A.R.; Guarneri, A.; Giglioli, F.R.; Ciammella, P.; Franco, P.; Mantovani, C.; Borasio, P.; Scagliotti, G.V.; Ragona, R. Stereotactic body radiation therapy for early stage nonsmall cell lung cancer: Results of a prospective trial. Lung Cancer 2010, 68, 72-77.
13. Lagerwaard, F.J.; Haasbeek, C.J.; Smit, E.F.; Slotman, B.J.; Senan, S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70, 685-692.
14. Uematsu, M.; Shioda, A.; Suda, A.; Fukui, T.; Ozeki, Y.; Hama, Y.; Wong, J.; Kusano, S. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: A 5-year experience. Int. J. Radiat. Oncol. Biol. Phys. 2001, 51, 666-670.
15. Xia, T.; Li, H.; Sun, Q.; Wang, Y.; Fan, N.; Yu, Y.; Li, P.; Chang, J. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2006, 66, 117-125.
16. Chang, J.; Liu, H.; Zhang, X. Four-dimensional CT and on-board volumetric image-guided stereotactic ablative radiotherapy for stage i nsclc. Int. J. Radiat. Oncol. Biol. Phys. 2011, in press.
17. Nagata, Y.; Hiraoka, M.; Shibata, T.; Onishi, H. A phase II trial of stereotactic body radiation therapy for operable non-small cell lung cancer: Japan clinical oncology group (JCOG 0403). Int. J. Radiat. Oncol. Biol. Phys. 2010, 78, S27.
18. Senan, S.; Verstegen, N.E.; Haasbeek, C.J.; Slotman, B.J.; Lagerwaard, F.J. Outcomes of stereotactic body radiotherapy in patients with clinical stage I non-small cell lung cancer who are fit to undergo surgery. J. Clin. Oncol. 2011, 29, Supplemental abstract 7051.
19. National Cancer Institutes. Cancer of the lung and bronchus SEER stat fact sheet. Available online: http://www.mesotheliomaattorneystoday.com/cancer/cancer-of-the-lung-and-bronchus-seerstat- fact-sheets.html (accessed on 1 June 2011).
20. Devereux, G. Abc of chronic obstructive pulmonary disease. Definition, epidemiology, and risk factors. Br. Med. J. 2006, 332, 1142-1144.
21. Young, R.P.; Hopkins, R.J.; Christmas, T.; Black, P.N.; Metcalf, P.; Gamble, G.D. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur. Respir. J. 2009, 34, 380-386.
22. Taylor, A.E.; Johnson, D.C.; Kazemi, H. Environmental tobacco smoke and cardiovascular disease. A position paper from the council on cardiopulmonary and critical care, american heart association. Circulation 1992, 86, 699-702.
23. Ambrose, J.A.; Barua, R.S. The pathophysiology of cigarette smoking and cardiovascular disease: An update. J. Am. Coll. Cardiol. 2004, 43, 1731-1737.
24. Pell, J.P.; Haw, S.; Cobbe, S.; Newby, D.E.; Pell, A.C.; Fischbacher, C.; McConnachie, A.; Pringle, S.; Murdoch, D.; Dunn, F. et al. Smoke-free legislation and hospitalizations for acute coronary syndrome. N. Engl. J. Med. 2008, 359, 482-491.
25. Wolf, P.A.; D'Agostino, R.B.; Kannel, W.B.; Bonita, R.; Belanger, A.J. Cigarette smoking as a risk factor for stroke. The Framingham study. J. Am. Med. Assoc. 1988, 259, 1025-1029.
26. Yacoub, R.; Habib, H.; Lahdo, A.; Al Ali, R.; Varjabedian, L.; Atalla, G.; Kassis Akl, N.; Aldakheel, S.; Alahdab, S.; Albitar, S. Association between smoking and chronic kidney disease: A case control study. BMC Public Health 2010, 10, 731.
27. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer statistics, 2010. CA Cancer J. Clin. 2010, 60, 277-300.
28. Falcoz, P.E.; Conti, M.; Brouchet, L.; Chocron, S.; Puyraveau, M.; Mercier, M.; Etievent, J.P.; Dahan, M. The thoracic surgery scoring system (thoracoscore): Risk model for in-hospital death in 15,183 patients requiring thoracic surgery. J. Thorac. Cardiovasc. Surg. 2007, 133, 325-332.
29. Chamogeorgakis, T.P.; Connery, C.P.; Bhora, F.; Nabong, A.; Toumpoulis, I.K. Thoracoscore predicts midterm mortality in patients undergoing thoracic surgery. J. Thorac. Cardiovasc. Surg. 2007, 134, 883-887.
30. Chamogeorgakis, T.; Toumpoulis, I.; Tomos, P.; Ieromonachos, C.; Angouras, D.; Georgiannakis, E.; Michail, P.; Rokkas, C. External validation of the modified thoracoscore in a new thoracic surgery program: Prediction of in-hospital mortality. Interact. Cardiovasc. Thorac. Surg. 2009, 9, 463-466.
31. Swanson, S.J.; Herndon II, J.E; D'Amico, T.A.; Demmy, T.L.; McKenna, R.J., Jr.; Green, M.R.; Sugarbaker, D.J. Video-assisted thoracic surgery lobectomy: Report of CALGB 39802-A prospective, multi-institution feasibility study. J. Clin. Oncol. 2007, 25, 4993-4997.
32. Chang, J.Y.; Roth, J.A. Stereotactic body radiation therapy for stage i non-small cell lung cancer. Thorac. Surg. Clin. 2007, 17, 251-259.
33. Liu, H.; Choi, B.; Zhang, J.; Tutt, T.; Chi, M.; Wang, C.; Luo, D.; Prado, K.; Mohan, R.; Dong, L. et al. Assessing respiration-induced tumor motion and margin of internal target volume for image-guided radiotherapy of lung cancers. Int. J. Radiat. Oncol. Biol. Phys. 2005, 63, S30.
34. Nehmeh, S.; Erdi, Y.; Pan, T.; Pevsner, A.; Rosenzweig, K.; Yorke, E.; Mageras, G.; Schoder, H.; Vernon, P.; Squire, O. et al. Four-dimensional (4D) PET/CT imaging of the thorax. Med. Phys. 2004, 31, 3179-3186.
35. Ramsey, C.; Scaperoth, D.; Arwood, D.; Oliver, A. Clinical efficacy of respiratory gated conformal radiation therapy. Med. Dosim. 1999, 24, 115-119.
36. Rosenzweig, K.; Hanley, J.; Mah, D.; Mageras, G.; Hunt, M.; Toner, S.; Burman, C.; Ling, C.; Mychalczak, B.; Fuks, Z. et al. The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2000, 48, 81-87.
37. Senan, S.; Palm, D.; Lagerwaard, F. Stereotactic ablative radiotherapy for stage I nsclc: Recent advances and controversies. J. Thorac. Dis. 2011, 3, in press.
38. Chang, J. Stereotactic ablative radiotherapy for stage I nsclc: Successes and existing challenges. J. Thorac. Dis. 2011, 3, (in press).
39. Palma, D.; Visser, O.; Lagerwaard, F.J.; Belderbos, J.; Slotman, B.J.; Senan, S. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: A population-based time-trend analysis. J. Clin. Oncol. 2010, 28, 5153-5159.
40. Kelly, P.; Balter, P.A.; Rebueno, N.; Sharp, H.J.; Liao, Z.; Komaki, R.; Chang, J.Y. Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. Int. J. Radiat. Oncol. Biol. Phys. 2010, 78, 1387-1393.
41. Whitson, B.A.; Groth, S.S.; Duval, S.J.; Swanson, S.J.; Maddaus, M.A. Surgery for early-stage non-small cell lung cancer: A systematic review of the video-assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy. Ann. Thorac. Surg. 2008, 86, 2008-2016, discussion 2016-2008.
42. Jemal, A.; Thun, M.J.; Ries, L.A.; Howe, H.L.; Weir, H.K.; Center, M.M.; Ward, E.; Wu, X.C.; Eheman, C.; Anderson, R. et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J. Natl. Cancer Inst. 2008, 100, 1672-1694.
43. Iakovou, I.; Schmidt, T.; Bonizzoni, E.; Ge, L.; Sangiorgi, G.M.; Stankovic, G.; Airoldi, F.; Chieffo, A.; Montorfano, M.; Carlino, M. et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. J. Am. Med. Assoc. 2005, 293, 2126-2130.
44. Grines, C.L.; Bonow, R.O.; Casey, D.E., Jr.; Gardner, T.J.; Lockhart, P.B.; Moliterno, D.J.; O'Gara, P.; Whitlow, P. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J. Am. Coll. Cardiol. 2007, 49, 734-739.
45. Kaluza, G.L.; Joseph, J.; Lee, J.R.; Raizner, M.E.; Raizner, A.E. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J. Am. Coll. Cardiol. 2000, 35, 1288-1294.
46. Sharma, A.K.; Ajani, A.E.; Hamwi, S.M.; Maniar, P.; Lakhani, S.V.; Waksman, R.; Lindsay, J. Major noncardiac surgery following coronary stenting: When is it safe to operate? Catheter. Cardiovasc. Interv. 2004, 63, 141-145.
47. Trial of either surgery or stereotactic radiotherapy for early stage (IA) lung cancer (ROSEL). 2011. Available online: http://clinicaltrials.gov/ct2/show/nct00687986 (accessed on 1 June 2011).
48. International randomized study to compare Cyberknife stereotactic radiotherapy with surgical resection in stage I non-small cell lung cancer (STARS). 2011. Available online: http://clinicaltrials.Gov/ct2/show/nct00840749 (accessed on 1 June 2011).
49. Surgery with or without internal radiation therapy compared with stereotactic body radiation therapy in treating patients with high-risk stage I non-small cell lung cancer. 2011. Available online: http://clinicaltrials.Gov/ct2/show/nct01336894?Term=acosog+z4099&rank=1 (accessed on 8 August 2011.)
50. Ginsberg, R.; Rubinstein, L. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung cancer study group. Ann. Thorac. Surg. 1995, 60, 615-622.
51. Crabtree, T.D.; Denlinger, C.E.; Meyers, B.F.; El Naqa, I.; Zoole, J.; Krupnick, A.S.; Kreisel, D.; Patterson, G.A.; Bradley, J.D. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 2010, 140, 377-386.
52. Stereotactic body radiation therapy in treating patients with stage I or stage II non-small cell lung cancer that can be removed by surgery (RTOG 0618). Available online: http://clinicaltrials.Gov/ ct2/show/nct00551369 (accessed on 1 June 2011).
53. Chen, H.Y.; Yu, S.L.; Chen, C.H.; Chang, G.C.; Chen, C.Y.; Yuan, A.; Cheng, C.L.; Wang, C.H.; Terng, H.J.; Kao, S.F. et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N. Engl. J. Med. 2007, 356, 11-20.
54. Seike, M.; Yanaihara, N.; Bowman, E.D.; Zanetti, K.A.; Budhu, A.; Kumamoto, K.; Mechanic, L.E.; Matsumoto, S.; Yokota, J.; Shibata, T. et al. Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier. J. Natl. Cancer Inst. 2007, 99, 1257-1269.
55. Tsao, M.S.; Aviel-Ronen, S.; Ding, K.; Lau, D.; Liu, N.; Sakurada, A.; Whitehead, M.; Zhu, C.Q.; Livingston, R.; Johnson, D.H. et al. Prognostic and predictive importance of p53 and ras for adjuvant chemotherapy in non small-cell lung cancer. J. Clin. Oncol. 2007, 25, 5240-5247.
56. Brock, M.V.; Hooker, C.M.; Ota-Machida, E.; Han, Y.; Guo, M.; Ames, S.; Glockner, S.; Piantadosi, S.; Gabrielson, E.; Pridham, G. et al. DNA methylation markers and early recurrence in stage I lung cancer. N. Engl. J. Med. 2008, 358, 1118-1128.
57. Stauder, M.C.; Macdonald, O.K.; Olivier, K.R.; Call, J.A.; Lafata, K.; Mayo, C.S.; Miller, R.C.; Brown, P.D.; Bauer, H.J.; Garces, Y.I. Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. Radiother. Oncol. 2011, 99, 166-171.
58. Nagata, Y.; Wulf, J.; Lax, I.; Timmerman, R.; Zimmermann, F.; Stojkovski, I.; Jeremic, B. Stereotactic radiotherapy of primary lung cancer and other targets: Results of consultant meeting of the international atomic energy agency. Int. J. Radiat. Oncol. Biol. Phys. 2011, 79, 660-669.
59. Timmerman, R.; McGarry, R.; Yiannoutsos, C.; Papiez, L.; Tudor, K.; DeLuca, J.; Ewing, M.; Abdulrahman, R.; DesRosiers, C.; Williams, M. et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J. Clin. Oncol. 2006, 24, 4833-4839.
60. Nagata, Y.; Hiraoka, M.; Mizowaki, T.; Narita, Y.; Matsuo, Y.; Norihisa, Y.; Onishi, H.; Shirato, H. Survey of stereotactic body radiation therapy in Japan by the Japan 3-D conformal external beam radiotherapy group. Int. J. Radiat. Oncol. Biol. Phys. 2009, 75, 343-347.
61. Joyner, M.; Salter, B.J.; Papanikolaou, N.; Fuss, M. Stereotactic body radiation therapy for centrally located lung lesions. Acta Oncol. 2006, 45, 802-807.
62. Forquer, J.A.; Fakiris, A.J.; Timmerman, R.D.; Lo, S.S.; Perkins, S.M.; McGarry, R.C.; Johnstone, P.A. Brachial plexopathy from stereotactic body radiotherapy in early-stage nsclc: Dose-limiting toxicity in apical tumor sites. Radiother. Oncol. 2009, 93, 408-413.
63. Voroney, J.P.; Hope, A.; Dahele, M.R.; Purdie, T.G.; Franks, K.N.; Pearson, S.; Cho, J.B.; Sun, A.; Payne, D.G.; Bissonnette, J.P. et al. Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer. J. Thorac. Oncol. 2009, 4, 1035-1037.
64. Dunlap, N.E.; Cai, J.; Biedermann, G.B.; Yang, W.; Benedict, S.H.; Sheng, K.; Schefter, T.E.; Kavanagh, B.D.; Larner, J.M. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76, 796-801.
65. Welsh, J.; Thomas, J.; Shah, D.; Allen, P.K.; Wei, X.; Mitchell, K.; Gao, S.; Balter, P.; Komaki, R.; Chang, J.Y. Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 2010. 81, 91-96.
66. Kong, F.M.; Ritter, T.; Quint, D.J.; Senan, S.; Gaspar, L.E.; Komaki, R.U.; Hurkmans, C.W.; Timmerman, R.; Bezjak, A.; Bradley, J.D. et al. Consideration of dose limits for organs at risk of thoracic radiotherapy: Atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int. J. Radiat. Oncol. Biol. Phys. 2010, (in press).
67. Chang, J.Y.; Balter, P.A.; Dong, L.; Yang, Q.; Liao, Z.; Jeter, M.; Bucci, M.K.; McAleer, M.F.; Mehran, R.J.; Roth, J.A. et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2008, 72, 967-971.
68. Timmerman, R.; Galvin, J.; Michalski, J.; Straube, W.; Ibbott, G.; Martin, E.; Abdulrahman, R.; Swann, S.; Fowler, J.; Choy, H. Accreditation and quality assurance for radiation therapy oncology group: Multicenter clinical trials using stereotactic body radiation therapy in lung cancer. Acta Oncol. 2006, 45, 779-786.
69. Stereotactic body radiation therapy in treating patients with stage I non-small cell lung cancer. 2011. Available online: http://clinicaltrials.gov/ct2/show/NCT00750269 (accessed on 1 June 2011).
70. Radiation therapy in treating patients with stage I non-small cell lung cancer. 2011 Available online: http://clinicaltrials.gov/ct2/show/NCT00960999 (accessed on 1 June 2011).
71. Nagata, Y.; Wulf, J.; Lax, I.; Timmerman, R.; Zimmermann, F.; Stojkovski, I.; Jeremic, B. Stereotactic radiotherapy of primary lung cancer and other targets: Results of consultant meeting of the international atomic energy agency. Int. J. Radiat. Oncol. Biol. Phys. 2011, 79, 660-669.
72. Matsuo, Y.; Nakamoto, Y.; Nagata, Y.; Shibuya, K.; Takayama, K.; Norihisa, Y.; Narabayashi, M.; Mizowaki, T.; Saga, T.; Higashi, T. et al. Characterization of FDG-pet images after stereotactic body radiation therapy for lung cancer. Radiother. Oncol. 2010, 97, 200-204.
73. Henderson, M.A.; Hoopes, D.J.; Fletcher, J.W.; Lin, P.F.; Tann, M.; Yiannoutsos, C.T.; Williams, M.D.; Fakiris, A.J.; McGarry, R.C.; Timmerman, R.D. A pilot trial of serial 18f-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76, 789-795.
74. Zhang, X.; Balter, P.; Pan, T.; Allen, P.; H, C.; Chang, J.Y. Pet/ct and outcome in lung cancer treated with stereotactic body radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 2010, 78, S16.
75. Neri, S.; Takahashi, Y.; Terashi, T.; Hamakawa, H.; Tomii, K.; Katakami, N.; Kokubo, M. Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers. J. Thorac. Oncol. 2010, 5, 2003-2007.